POINT Biopharma Global Inc

:RACA   9:58:40 AM EDT
8.01
+0.01 (+0.12%)
Debt Financing / Related, Exchange Changes, Mergers / Acquisitions

POINT Biopharma To List On Nasdaq Through Merger With Research Alliance Corp I

Published: 03/15/2021 10:19 GMT
(RACA) - Next-generation Radiopharmaceuticals Company Point Biopharma to List on Nasdaq Through Merger With Research Alliance Corpipoint Biopharma - Expected to Receive About $300 Million in Proceeds Through Business Combination.
Point Biopharma - Upon Closing, Combined Company Expected to Be Listed on Nasdaq Under Ticker Symbol "pnt".
Point Biopharma - Proceeds From Deal Include a $165 Million Fully-committed Pipe Led by Ra Capital Management and Other Top-tier Investors.
Point Biopharma - Proceeds Will Be Used to Fund Point's Unique Radiopharmaceutical Platform.
Point Biopharma - Combined Company is Expected to Have Initial Equity Value of About $924 Million.